Monoclonal antibody combination prevents Covid-19 in previously uninfected household contacts of infected persons |
Editorial
eMediNexus Coverage from: 
Monoclonal antibody combination prevents Covid-19 in previously uninfected household contacts of infected persons
Dr Rahul Pandit, Director, Critical Care, Fortis hospital, Mumbai; Member, COVID-19 Task Force, Maharashtra Government,  28 September 2021
Coronavirus Live Count Map India

remove_red_eye 549 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Infectious Diseases #Multispeciality

3 Read Comments                

The combination of casirivimab and imdevimab is approved for emergency use to prevent Covid-19 in high-risk adults and children (older than 12 years of age and weighing at least 40 kg) who likely to develop severe COVID-19, including hospitalization or death.Now a New England Journal of Medicine study has shown that the two monoclonal antibodies, casirivimab and imdevimab administered together, also prevented symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection in previously uninfected hou...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now